Bulavin DV - Search Results

1

Attenuation of p38α MAPK stress response signaling delays the in vivo aging of skeletal muscle myofibers and progenitor cells.

Papaconstantinou J, Wang CZ, Zhang M, Yang S, Deford J, Bulavin DV, Ansari NH. Papaconstantinou J, et al. Among authors: bulavin dv. Aging (Albany NY). 2015 Sep;7(9):718-33. doi: 10.18632/aging.100802. Aging (Albany NY). 2015. PMID: 26423835 Free PMC article.

2

Aged dominant negative p38α MAPK mice are resistant to age-dependent decline in adult-neurogenesis and context discrimination fear conditioning.

Cortez I, Bulavin DV, Wu P, McGrath EL, Cunningham KA, Wakamiya M, Papaconstantinou J, Dineley KT. Cortez I, et al. Among authors: bulavin dv. Behav Brain Res. 2017 Mar 30;322(Pt B):212-222. doi: 10.1016/j.bbr.2016.10.023. Epub 2016 Oct 17. Behav Brain Res. 2017. PMID: 27765672 Free PMC article.

3

LSEC model of aging.

Grosse L, Bulavin DV. Grosse L, et al. Among authors: bulavin dv. Aging (Albany NY). 2020 Jun 13;12(11):11152-11160. doi: 10.18632/aging.103492. Epub 2020 Jun 13. Aging (Albany NY). 2020. PMID: 32535553 Free PMC article.

4

Defined p16^High Senescent Cell Types Are Indispensable for Mouse Healthspan.

Grosse L, Wagner N, Emelyanov A, Molina C, Lacas-Gervais S, Wagner KD, Bulavin DV. Grosse L, et al. Among authors: bulavin dv. Cell Metab. 2020 Jul 7;32(1):87-99.e6. doi: 10.1016/j.cmet.2020.05.002. Epub 2020 Jun 1. Cell Metab. 2020. PMID: 32485135 Free article.

5

p38 MAP kinase's emerging role as a tumor suppressor.

Bulavin DV, Fornace AJ Jr. Bulavin DV, et al. Adv Cancer Res. 2004;92:95-118. doi: 10.1016/S0065-230X(04)92005-2. Adv Cancer Res. 2004. PMID: 15530558 Review.

6

p38MAPK builds a hyaluronan cancer niche to drive lung tumorigenesis.

Brichkina A, Bertero T, Loh HM, Nguyen NT, Emelyanov A, Rigade S, Ilie M, Hofman P, Gaggioli C, Bulavin DV. Brichkina A, et al. Among authors: bulavin dv. Genes Dev. 2016 Dec 1;30(23):2623-2636. doi: 10.1101/gad.290346.116. Genes Dev. 2016. PMID: 28007785 Free PMC article.

7

p38MAPK controls expression of multiple cell cycle inhibitors and islet proliferation with advancing age.

Wong ES, Le Guezennec X, Demidov ON, Marshall NT, Wang ST, Krishnamurthy J, Sharpless NE, Dunn NR, Bulavin DV. Wong ES, et al. Among authors: bulavin dv. Dev Cell. 2009 Jul;17(1):142-9. doi: 10.1016/j.devcel.2009.05.009. Dev Cell. 2009. PMID: 19619499 Free article.

8

Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.

Shreeram S, Hee WK, Demidov ON, Kek C, Yamaguchi H, Fornace AJ Jr, Anderson CW, Appella E, Bulavin DV. Shreeram S, et al. Among authors: bulavin dv. J Exp Med. 2006 Dec 25;203(13):2793-9. doi: 10.1084/jem.20061563. Epub 2006 Dec 11. J Exp Med. 2006. PMID: 17158963 Free PMC article.

9

Cancer suppression by systemic inactivation of p38MAPK.

Brichkina A, Bulavin DV. Brichkina A, et al. Among authors: bulavin dv. Oncotarget. 2017 Feb 28;8(9):14275-14276. doi: 10.18632/oncotarget.15293. Oncotarget. 2017. PMID: 28199960 Free PMC article. No abstract available.

10

Proline isomerisation as a novel regulatory mechanism for p38MAPK activation and functions.

Brichkina A, Nguyen NT, Baskar R, Wee S, Gunaratne J, Robinson RC, Bulavin DV. Brichkina A, et al. Among authors: bulavin dv. Cell Death Differ. 2016 Oct;23(10):1592-601. doi: 10.1038/cdd.2016.45. Epub 2016 May 27. Cell Death Differ. 2016. PMID: 27233083 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters